Phenotypically, infant ALL is often an early B-cell precursor and is associated with CD10 negativity and co-expression of myeloid antigens, which has been linked with these types of leukemia being resistant to standard ALL-based therapy (6, 12). The gene discussed is MME; the disease is acute lymphoblastic leukemia.